期刊文献+

毛壳素对肝内胆管癌细胞的影响及其机制 被引量:1

The effect and mechanism of chaetocin on the intrahepatic cholangiocarcinoma cells
原文传递
导出
摘要 目的 观察毛壳素对人肝内胆管癌细胞CCLP-1活性的影响并探讨其相关作用机制。 方法 毛壳素以不同浓度分为1组(0 nmol/L)、2组(50 nmol/L)、3组(100 nmol/L)和4组(200 nmol/L)与CCLP-1细胞共培养,细胞增殖法检测CCLP-1细胞活性;吉姆赛染色观察CCLP-1细胞形态学改变;流式细胞技术检测细胞凋亡;荧光显微镜检测CCLP-1胞内活性氧(ROS);蛋白质印迹法检测凋亡信号调节激酶1(ASK-1)、c-Jun氨基末端激酶(JNK)蛋白表达。结果 细胞增殖法提示毛壳素随浓度增加及作用细胞时间延长,细胞活性抑制率上升,呈剂量-效应关系(F=102.369,P=0.000)及时间-效应关系(F=141.377,P=0.000),并剂量与时间呈交互作用(F=15.418,P=0.000);CCLP-1细胞经毛壳素作用后吉姆赛染色可见细胞核固缩,出现分页状、碎片形状及凋亡小体。流式细胞技术显示细胞总凋亡率:1组:(6.42±3.10)%;2组:(10.82±2.84)%;3组:(13.67±1.71)%和4组:(17.91±6.16)%,总凋亡率呈增多趋势并差异有统计学意义(F=4.788,P=0.034);荧光显微镜检测实验组细胞内荧光值(24.126±9.587)高于空白组荧光值(5.114±1.937)并差异有统计学意义(P=0.006);Western blot法实验显示磷酸化ASK-1蛋白表达量:0.255±0.150 (1组)、0.680±0.039(2组)、1.356±0.125(3组)和1.916±0.367(4组)。磷酸化JNKs蛋白表达量:0.493±0.233(1组)、1.542±0.573(2组)、1.639±0.342(3组)、2.480±1.001(4组),提示随毛壳素浓度增加各蛋白表达量均上调(ASK-1:F=36.946,P=0.000,JNKs:F=5.291,P=0.027)。 结论 毛壳素对CCLP-1细胞有显著抑制作用并诱导其凋亡,并且ROS-ASK-1/JNKs信号参与CCLP-1细胞凋亡。 Objective To investigate the effect of chaetocin on the intrahepatic cholangiocarcinoma CCLP-1 and explore the potential mechanism.Methods The concentration of chaetocin were divided into 4 groups: Group 1: 0 nmol/L, Group 2: 50 nmol/L, Group 3: 100 nmol/L and Group 4: 200 nmol/L, and all were co-cultured with CCLP-1 cell, respectively. Cell viability was detected by Cell Counting Kit-8 assay; Giemsa staining was used to observe the cell morphological and flow cytometry technique were used to detect cell apoptosis; The intracellular reactive oxygen species (ROS) level was detected using fluorescent probe under fluorescence microscope; Western blotting were used to measure the expression of Apoptosis signal-regulating kinase 1 (ASK-1) and c-Jun N-terminal kinase (JNKs).Results The proliferation of CCLP-1 cell was inhibited by chaetocin in dose dependent (F=102.369, P=0.000) or in time dependent (F=141.377, P=0.000). Furthermore, both have interaction (F=15.418, P=0.000). Giemsa staining showed chaetocin brought about CCLP-1 cell to present morphological characteristics of apoptosis, and flow cytometry indicated title rate of apoptosis of CCLP-1 cell were (6.42±3.10)%, (10.82±2.84)%, (13.67±1.71)% and (17.91±6.16)%, and apoptosis was significantly increased (F=4.788, P=0.034). The intracellular ROS level of treatment group (24.126±9.587) was much higher than that of control group (5.114±1.937) and had significantly difference (P=0.006). Western blotting showed the expressions of p-ASK-1 were 0.255±0.150, 0.680±0.039, 1.356±0.125 and 1.916±0.367. The expressions of JNKs were 0.493±0.233, 1.542±0.573, 1.639±0.342 and 2.480±1.001.Both proteins expressed increasingly as dose of chaetocin increased. (ASK-1: F=36.946, P=0.000, JNKs: F=5.291, P=0.027). Conclusion Chaetocin could inhibit CCLP-1 cell and induce it apoptosis via promote ROS mediate ASK-1/JNK signal.
出处 《中华实验外科杂志》 CSCD 北大核心 2017年第4期599-601,共3页 Chinese Journal of Experimental Surgery
基金 广东省自然科学基金(2015A030313725)
关键词 毛壳素 人肝内胆管癌细胞 细胞凋亡 活性氧 Chaetocin Human intrahepatic cholangiocarcinoma cell Apoptosis Oxygen species
  • 相关文献

参考文献1

二级参考文献11

  • 1Everhart JE,Ruhl CE.Burden of digestive diseases in the United States Part III :liver,liiliary tract,and pancreas[J].Gastroenterology,2009,126(4):1124-1144.
  • 2Sapisochin G,Fidelman N ,Roberts JP,et al.Mixed hepatocellular cholangiocarcinoma and intrahepatit, cholangitx-arcinoma in patients undergoing transplantation for hepatocellular carcinoma [J].Liver Transpl,2011 ,17(8):934-942.
  • 3Valle J,Wasan H ,Palmer DH ,et al.Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer [J].N Engl J Med,2010,362(14):1273-1281.
  • 4Szyf M.Prospects for the development of epigenetic drugs for CNS conditions[J].Nat Rev Drug Discov ,2015 ,14(7):461-474.
  • 5Gao Y,Yang M,Jiang Z,et al.FMP3 expression is associated with poor outcome and epigenetic deregulation in intrahepatic cholangiocar- cinoma[J].Hum Pathol,2014,45(6):1184-1191.
  • 6Udali S,Guarini P,Moruzzi S,et al.Global DNA metIiylation and hydroxymethylation differ in hepatocellular carcinoma and cholangio- carcinoma and relate to survival rate[J].Hepatology,2015 ,62(2):496-504.
  • 7Sriraksa R,Limpaiboon T.Histone deacetylases and their inhibitors as potential therapeutic drugs for cholangiocarcinoma-cell line findings [J].Asian Pac J Cancer Prev,2012,14(4):2503-2508.
  • 8Morine Y,Shimada iM ,Iwahashi S,et al.Role of histone deacetylase expression in intraliepatic cholangiocarcinoma[J].Surgery,2012,151(3):412-419.
  • 9Deubzer HE,Ehemann V,Westennann F,et ul.Histone deacetylase inhibitor Helminthosporium carbonum ( HC )-toxin suppresses the malignant phenotype of neuroblastoma cells [J].Int J Cancer,2008 ,122(8):1891-1900.
  • 10殷晓煜,彭建新.表观遗传学在恶性肿瘤领域的研究现状与展望[J].中华实验外科杂志,2009,26(1):7-8. 被引量:7

共引文献2

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部